GDP Non-Compliance Report for Belgian Wholesale Distributor
Recommendation
1/2 December 2026
Bring and Keep your Organisation in Compliance with the GDP Regulations
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
End of October 2022, the Competent Authority of Belgium (Federal Agency for Medicines and Health Products) added a new GDP Non-Compliance Report to the EudraGMDP database.
The document dated 21 October 2022 goes back to an inspection conducted on 07 October 2022 at a wholesale distributor in Bierbeek, Belgium.
The authority blames the company in question for a whole series of GDP violations:
- "Importation of medicinal products without importation authorization
- sales of medicinal products to non-authorized societies
- holding of medicinal products in non-authorized rooms
- distribution of API without API registration
- RP does not properly perform his or her duties"
As a consequence, the wholesale distribution authorisation (WDA) was suspended.
Source: EudraGMDP Database (Inspection Date: 07 October 2022; Report Number: BE/NC/2022/03). * * To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September